论文部分内容阅读
目的探讨盐酸利托君与硫酸镁治疗先兆早产疗效比较。方法将2006年1月至2010年1月诊断为先兆早产的患者共860例,随机分组,分别使用盐酸利托君治疗540例(治疗组)和硫酸镁治疗320例(对照组),并观察有效用药时间、延长妊娠时间及妊娠结局。结果治疗组有效用药时间、延长妊娠时间及妊娠结局与照组比较差异均有统计学意义(P<0.05)。结论盐酸利托君对先兆早产治疗效果优于硫酸镁,盐酸利托君是防治早产的安全有效的药物,值得临床推广使用。
Objective To investigate the efficacy of risoterine hydrochloride and magnesium sulfate in the treatment of threatened preterm labor. Methods A total of 860 patients diagnosed as threatened preterm labor from January 2006 to January 2010 were randomly divided into treatment group (540 cases) and magnesium sulfate treatment group (320 cases) (control group), and were observed Effective medication time, prolonging pregnancy time and pregnancy outcome. Results The treatment group effective use of time, prolonged pregnancy and pregnancy outcomes compared with the control group were statistically significant (P <0.05). Conclusion Rituxuron hydrochloride is superior to magnesium sulfate in the treatment of threatened premature delivery. Ritodrine hydrochloride is a safe and effective drug for prevention and treatment of premature labor and is worthy of clinical promotion.